Prospective, Longitudinal, Multinational Registry of Patients with Newly Diagnosed Peripheral T-Cell Lymphoma
Conditions
Peripheral T-cell Lymphoma
What is the purpose of this trial?
The COMPLETE registry is a prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices. The registry will enroll newly-diagnosed patients with PTCL treated with a variety of regimens. The COMPLETE registry is designed to better understand PTCL patient characteristics, treatments, and outcomes to help design and understand future clinical trials.
Participation Guidelines
- Age:
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Spectrum Pharmaceuticals, Inc
- Dates:
- February 2010
- Last Updated:
- May 8, 2013
- Study HIC#:
- 1008007318
Clinicaltrials.gov ID: NCT01110733
For more information about this trial, contact:
Melody Sacatos
(203) 737-4512
melody.sacatos@yale.edu
Investigators
Francine Foss, MD
Principal Investigator
Francine Foss, MD
Study Chair
